Parkinson’s Foundation staff presents ten groundbreaking research programs at the conference in Kyoto, Japan
MIAMI & NEW YORK (June 4, 2019) — The Parkinson’s Foundation will join the global Parkinson’s community at the 5th World Parkinson Congress (WPC) in Kyoto, Japan from June 4-7, 2019 to provide an international forum to learn about the latest advancements in Parkinson’s disease (PD). The Parkinson’s Foundation is proud to be a silver supporter of the WPC and will be exhibiting at booth #510 at the Kyoto International Conference Center.
Parkinson’s Foundation experts will present ten research posters on various topics aimed at driving new ideas and collaboration at WPC. Research topics that will be presented include: ‘Impact of Offering Genetic Testing and Counseling to People with Parkinson's Disease in a Clinical Setting,’ ‘Improving Clinical Trials Through the Science of Patient Engagement;’ ‘Spanish Language Educational Programming - Serving Diverse Communities;’ and more. The research will be presented by the authors to WPC attendees.
“We are thrilled to join the global Parkinson community at WPC and to collaborate with those who share our vision of helping people with Parkinson’s disease live better,” said John L. Lehr, Parkinson’s Foundation chief executive officer. “We look forward to sharing our latest research findings at WPC, where clinicians, scientists, people with Parkinson’s and their care partners in attendance can benefit from this new information.”
Parkinson’s Foundation staff have also been selected to host sessions about critical issues central to the global Parkinson’s community, like the pre-congress session on “Understanding Genetics and Parkinson’s: A Powerful Tool for Improving Research, Care & Quality of Life.” Foundation staff will also demonstrate, through research findings, the importance of patient engagement in research and a closer look at the unmet needs, research and care priorities for women with Parkinson's.
“Our hope is that the research presented at the World Parkinson Congress will drive collaborations that make a tangible difference in advancing treatments,” said Jim Beck, PhD, Parkinson’s Foundation chief scientific officer. “We are incredibly proud to join our colleagues at WPC on this global stage as we work together to advance research towards a cure.”
Parkinson’s Foundation patient advocates will be in attendance driving awareness of the importance of global collaboration.
About the Parkinson’s Foundation
The Parkinson’s Foundation makes life better for people with Parkinson’s disease by improving care and advancing research toward a cure. In everything we do, we build on the energy, experience and passion of our global Parkinson’s community. Since 1957, the Parkinson’s Foundation has invested more than $400 million in Parkinson’s research and clinical care. Connect with us on Parkinson.org, Facebook, Twitter, Instagram or call (800) 4PD-INFO (473-4636).
About Parkinson’s Disease
Affecting an estimated one million Americans and 10 million worldwide, Parkinson’s disease is the second-most common neurodegenerative disease after Alzheimer’s and is the 14th-leading cause of death in the U.S. It is associated with a progressive loss of motor control (e.g., shaking or tremor at rest and lack of facial expression), as well as non-motor symptoms (e.g., depression and anxiety). There is no cure for Parkinson’s and 60,000 new cases are diagnosed each year in the U.S. alone.